LCOV
PFE icon

London Company of Virginia’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.23M Sell
50,627
-25,640
-34% -$622K 0.01% 139
2025
Q1
$1.93M Sell
76,267
-33,341
-30% -$845K 0.01% 132
2024
Q4
$2.91M Sell
109,608
-929,462
-89% -$24.7M 0.02% 129
2024
Q3
$30.1M Sell
1,039,070
-31,429
-3% -$910K 0.16% 93
2024
Q2
$30M Sell
1,070,499
-57,366
-5% -$1.61M 0.17% 90
2024
Q1
$31.3M Buy
1,127,865
+154,146
+16% +$4.28M 0.16% 88
2023
Q4
$28M Sell
973,719
-1,784,711
-65% -$51.4M 0.16% 91
2023
Q3
$91.5M Sell
2,758,430
-4,518,686
-62% -$150M 0.55% 59
2023
Q2
$267M Sell
7,277,116
-175,201
-2% -$6.43M 1.51% 23
2023
Q1
$304M Sell
7,452,317
-198,592
-3% -$8.1M 1.76% 16
2022
Q4
$392M Buy
7,650,909
+4,181
+0.1% +$214K 2.31% 10
2022
Q3
$335M Buy
7,646,728
+196,013
+3% +$8.58M 2.12% 9
2022
Q2
$391M Sell
7,450,715
-243,878
-3% -$12.8M 2.39% 7
2022
Q1
$398M Buy
7,694,593
+265,281
+4% +$13.7M 2.1% 11
2021
Q4
$439M Buy
7,429,312
+3,171
+0% +$187K 2.21% 8
2021
Q3
$319M Buy
7,426,141
+172,670
+2% +$7.43M 1.75% 18
2021
Q2
$284M Buy
7,253,471
+55,739
+0.8% +$2.18M 1.51% 27
2021
Q1
$261M Sell
7,197,732
-11,070
-0.2% -$401K 1.5% 28
2020
Q4
$265M Buy
7,208,802
+83,926
+1% +$3.09M 1.66% 20
2020
Q3
$261M Buy
7,124,876
+33,123
+0.5% +$1.22M 1.86% 17
2020
Q2
$232M Buy
7,091,753
+161,522
+2% +$5.28M 1.8% 18
2020
Q1
$226M Sell
6,930,231
-304,625
-4% -$9.94M 2.16% 10
2019
Q4
$283M Sell
7,234,856
-132,982
-2% -$5.21M 2.18% 9
2019
Q3
$265M Buy
7,367,838
+2,422,576
+49% +$87M 2.18% 10
2019
Q2
$214M Buy
4,945,262
+21,432
+0.4% +$928K 1.84% 19
2019
Q1
$209M Sell
4,923,830
-79,986
-2% -$3.4M 1.79% 20
2018
Q4
$218M Sell
5,003,816
-369,579
-7% -$16.1M 2.09% 10
2018
Q3
$237M Sell
5,373,395
-112,833
-2% -$4.97M 1.84% 16
2018
Q2
$199M Sell
5,486,228
-103,137
-2% -$3.74M 1.63% 22
2018
Q1
$198M Sell
5,589,365
-712,957
-11% -$25.3M 1.59% 21
2017
Q4
$228M Sell
6,302,322
-525,668
-8% -$19M 1.65% 22
2017
Q3
$244M Sell
6,827,990
-161,481
-2% -$5.76M 1.75% 18
2017
Q2
$235M Buy
6,989,471
+31,071
+0.4% +$1.04M 1.59% 21
2017
Q1
$238M Buy
6,958,400
+321,191
+5% +$11M 1.57% 22
2016
Q4
$216M Buy
6,637,209
+824,002
+14% +$26.8M 1.48% 23
2016
Q3
$197M Buy
5,813,207
+428,663
+8% +$14.5M 1.47% 23
2016
Q2
$190M Buy
5,384,544
+199,879
+4% +$7.04M 1.46% 22
2016
Q1
$154M Sell
5,184,665
-690,094
-12% -$20.5M 1.26% 34
2015
Q4
$190M Buy
5,874,759
+648,999
+12% +$20.9M 1.64% 17
2015
Q3
$164M Buy
5,225,760
+244,270
+5% +$7.67M 1.52% 25
2015
Q2
$167M Buy
4,981,490
+709,266
+17% +$23.8M 1.45% 23
2015
Q1
$149M Buy
4,272,224
+615,382
+17% +$21.4M 1.37% 31
2014
Q4
$114M Buy
3,656,842
+425,888
+13% +$13.3M 1.19% 34
2014
Q3
$95.5M Buy
3,230,954
+150,385
+5% +$4.45M 1.07% 40
2014
Q2
$91.4M Buy
3,080,569
+291,019
+10% +$8.64M 1% 44
2014
Q1
$89.6M Buy
2,789,550
+119,779
+4% +$3.85M 1.01% 41
2013
Q4
$81.8M Buy
2,669,771
+451,690
+20% +$13.8M 0.93% 44
2013
Q3
$63.7M Buy
2,218,081
+171,563
+8% +$4.93M 0.87% 44
2013
Q2
$57.3M Buy
+2,046,518
New +$57.3M 0.83% 47